Zhuang Liu

TL;DR: The proposed implantable blood clot cancer vaccine can be readily made by mixing the blood from patients with cancer with immunomodulating agents ex vivo, followed by reimplantation into the same patient for personalized cancer immunotherapy in future clinical translation.

TL;DR: Bimetallic oxide FeWOX NSs are highlighted as an enzyme-mimetic nanoplatform for imaging of the tumor microenvironment and could also be employed as promising nanoagents for multimodal computed tomography and magnetic resonance imaging of tumors, due to the strong X-ray attenuation ability of W element and high MR contrast ability of Fe element.

TL;DR: A unique hydrogel-based delivery system using clinically approved drugs is presented, showing promise in improving the objective response rate of ICB therapy and minimizing its systemic toxicity.

TL;DR: Double-PEGylated biocompatible reduced graphene oxide nanosheets anchored with iron oxide nanoparticles exhibited a prolonged blood circulation half-life and remarkable tumor accumulation and multimodality imaging combining positron emission tomography imaging with magnetic resonance imaging (MRI) and photoacoustic imaging was successfully achieved.

TL;DR: Recent studies have developed different methods for exosome labeling and imaging, which have allowed for in vivo investigation of their bio-distribution, physiological functions, migration, and targeting mechanisms, which are expected to greatly advance exosomes-based nanomedicine applications.